{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:50:59Z","timestamp":1792752659976,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 159538"],"award-info":[{"award-number":["PJT 159538"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115671","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:42:38Z","timestamp":1697154158000},"page":"115671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Salsalate and\/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice"],"prefix":"10.1016","volume":"168","author":[{"given":"Hesham","family":"Shamshoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D.","family":"Medak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg L.","family":"McKie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Jeromson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2023.115671_bib1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib3","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.9778\/cmajo.20140009","article-title":"Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study","volume":"2","author":"Pringsheim","year":"2014","journal-title":"CMAJ Open"},{"issue":"5","key":"10.1016\/j.biopha.2023.115671_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4088\/JCP.08m04912gre","article-title":"Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients","volume":"71","author":"Procyshyn","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2023.115671_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","article-title":"Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis","volume":"47","author":"Stogios","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2023.115671_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.smrv.2016.05.002","article-title":"The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia","volume":"33","author":"Monti","year":"2017","journal-title":"Sleep. Med Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115671_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ecl.2013.05.006","article-title":"Effects of antipsychotic medications on appetite, weight, and insulin resistance","volume":"42","author":"Deng","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.biopha.2023.115671_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology","author":"Rojo","year":"2015","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad025","article-title":"Antipsychotic-induced alterations in lipid turnover","volume":"164","author":"Pereira","year":"2023","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2023.115671_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)","volume":"24","author":"De Hert","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.biopha.2023.115671_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphar.2018.00181","article-title":"Naltrexone and bupropion combination treatment for smoking cessation and weight loss in patients with schizophrenia","volume":"9","author":"Lyu","year":"2018","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115671_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4088\/JCP.v69n0503","article-title":"Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial","volume":"69","author":"Joffe","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ebmental-2021-300291","article-title":"Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology","volume":"25","author":"Fitzgerald","year":"2022","journal-title":"Evid. Based Ment. Health"},{"issue":"31","key":"10.1016\/j.biopha.2023.115671_bib15","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.biopha.2023.115671_bib16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/appi.ajp.2013.12010127","article-title":"Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder","volume":"170","author":"Jarskog","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12669\/pjms.35.1.100","article-title":"Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus","volume":"35","author":"Rashid","year":"2019","journal-title":"Pak. J. Med Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib18","first-page":"242","article-title":"Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus","volume":"9","author":"Becker","year":"2009","journal-title":"Pharm. J."},{"issue":"12","key":"10.1016\/j.biopha.2023.115671_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/14740338.2019.1674809","article-title":"Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia","volume":"18","author":"Marteene","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.biopha.2023.115671_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1369-5266(98)80264-1","article-title":"Jasmonate and salicylate as global signals for defense gene expression","volume":"1","author":"Reymond","year":"1998","journal-title":"Curr. Opin. Plant Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2023.115671_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann. Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2023.115671_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.04.028","article-title":"Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia","volume":"147","author":"Keller","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.biopha.2023.115671_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ebiom.2017.08.004","article-title":"Salsalate activates skeletal muscle thermogenesis and protects mice from high-fat diet induced metabolic dysfunction","volume":"23","author":"Nie","year":"2017","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.biopha.2023.115671_bib25","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.2337\/db16-0564","article-title":"Salsalate (salicylate) uncouples mitochondria, improves glucose homeostasis, and reduces liver lipids independent of AMPK-beta1","volume":"65","author":"Smith","year":"2016","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2023.115671_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032579","article-title":"Low-dose sodium salicylate promotes ovulation by regulating steroids via CYP17A1","volume":"24","author":"Li","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib27","first-page":"222","article-title":"Transcriptional profile of HCV replicon cells after treatment with acetylsalicylic acid","volume":"52","author":"Rios-Ibarra","year":"2022","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.biopha.2023.115671_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2018.08.162","article-title":"Metabolism of liver CYP450 and ultrastructural changes after long-term administration of aspirin and ibuprofen","volume":"108","author":"Wen","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(25)12326-4","article-title":"Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine","volume":"276","author":"Ring","year":"1996","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148539","article-title":"Application of plasma levels of olanzapine and n-desmethyl-olanzapine to monitor clinical efficacy in patients with schizophrenia","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115671_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/oby.23630","article-title":"Thermoneutral housing and preexisting obesity do not abolish the sexually dimorphic effects of olanzapine on weight gain in mice","author":"Seguin","year":"2023","journal-title":"Obes. (Silver Spring)"},{"issue":"9","key":"10.1016\/j.biopha.2023.115671_bib32","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.biopha.2023.115671_bib33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/jcp.0b013e31815a8872","article-title":"Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study","volume":"27","author":"Kluge","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115671_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115225","article-title":"The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse","volume":"9","author":"Morgan","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cmet.2016.03.010","article-title":"Are metformin doses used in murine cancer models clinically relevant?","volume":"23","author":"Chandel","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib36","doi-asserted-by":"crossref","first-page":"G166","DOI":"10.1152\/ajpgi.00097.2018","article-title":"Acute administration of IL-6 improves indices of hepatic glucose and insulin homeostasis in lean and obese mice","volume":"316","author":"Peppler","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115671_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","article-title":"New methods for calculating metabolic rate with special reference to protein metabolism","volume":"109","author":"Weir","year":"1949","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115671_bib38","doi-asserted-by":"crossref","first-page":"E563","DOI":"10.1152\/ajpendo.00287.2014","article-title":"Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice","volume":"307","author":"MacPherson","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2023.115671_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/gerona\/glt156","article-title":"Aging-associated reductions in lipolytic and mitochondrial proteins in mouse adipose tissue are not rescued by metformin treatment","volume":"69","author":"Mennes","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"10.1016\/j.biopha.2023.115671_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.835154","article-title":"Adipose tissue insulin resistance is positively associated with serum uric acid levels and hyperuricemia in northern chinese adults","volume":"13","author":"Sun","year":"2022","journal-title":"Front Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115671_bib41","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1113\/JP282922","article-title":"Fasting or the short-term consumption of a ketogenic diet protects against antipsychotic-induced hyperglycaemia in mice","volume":"600","author":"Shamshoum","year":"2022","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115671_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib43","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1152\/ajpendo.00226.2017","article-title":"Subcutaneous inguinal white adipose tissue is responsive to, but dispensable for, the metabolic health benefits of exercise","volume":"314","author":"Peppler","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.biopha.2023.115671_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1042\/BCJ20190466","article-title":"Biochemical adaptations in white adipose tissue following aerobic exercise: from mitochondrial biogenesis to browning","volume":"477","author":"McKie","year":"2020","journal-title":"Biochem J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib46","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00676.2007","article-title":"Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice","volume":"294","author":"Lee","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib47","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1159\/000494573","article-title":"Atypical antipsychotic drug olanzapine deregulates hepatic lipid metabolism and aortic inflammation and aggravates atherosclerosis","volume":"50","author":"Chen","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib48","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/s41598-022-09610-1","article-title":"Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRalpha\/PCSK9 pathway","volume":"12","author":"Zhu","year":"2022","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.biopha.2023.115671_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249362","article-title":"Understanding mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in mental illness: risperidone and olanzapine alter the hepatic proteomic signature in mice","volume":"21","author":"Rostama","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12916-020-01713-8","article-title":"Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches","volume":"18","author":"Soto-Angona","year":"2020","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.biopha.2023.115671_bib51","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"FASEB J."},{"issue":"5389","key":"10.1016\/j.biopha.2023.115671_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.282.5389.751","article-title":"An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits","volume":"282","author":"Wetterau","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib53","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jc.2017-00047","article-title":"How to measure adipose tissue insulin sensitivity","volume":"102","author":"Sondergaard","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115671_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.06.020","article-title":"Lipolysis triggers a systemic insulin response essential for efficient energy replenishment of activated brown adipose tissue in mice","volume":"28","author":"Heine","year":"2018","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.biopha.2023.115671_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5483\/BMBRep.2022.55.6.026","article-title":"Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance","volume":"55","author":"Kim","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.biopha.2023.115671_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117442","article-title":"Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels","volume":"247","author":"Singh","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115671_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110912","article-title":"Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats","volume":"133","author":"Guo","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-020-05677-8","article-title":"Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats","volume":"238","author":"Luo","year":"2021","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.biopha.2023.115671_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112859","article-title":"Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain","volume":"220","author":"Zapata","year":"2020","journal-title":"Physiol. Behav."},{"issue":"8","key":"10.1016\/j.biopha.2023.115671_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrendo.2017.48","article-title":"Warming the mouse to model human diseases","volume":"13","author":"Ganeshan","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Pt B","key":"10.1016\/j.biopha.2023.115671_bib61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2018.02.040","article-title":"Challenges in quantifying food intake in rodents","volume":"1693","author":"Ali","year":"2018","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115671_bib62","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115671_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/BJ20150125","article-title":"Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity","volume":"468","author":"Ford","year":"2015","journal-title":"Biochem J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115671_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YIC.0000000000000204","article-title":"Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study","volume":"33","author":"Luo","year":"2018","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:39:09Z","timestamp":1779917949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":64,"alternative-id":["S0753332223014695"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115671","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salsalate and\/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115671"}}